Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target
Stefano Palomba,
No information about this author
Giuseppe Seminara,
No information about this author
Flavia Costanzi
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(12), P. 2859 - 2859
Published: Dec. 16, 2024
Background:
Chemerin,
an
adipokine
implicated
in
inflammatory,
metabolic,
and
adipogenic
processes,
has
been
detected
high
serum
concentration
women
with
polycystic
ovary
syndrome
(PCOS)
seems
to
play
a
role
PCOS
pathogenesis.
Moreover,
at
present,
no
comprehensive
critical
document
is
available
the
literature
on
this
topic.
The
aim
of
current
study
was
comprehensively
review
latest
data
confirm
evidence
about
association
between
chemerin
PCOS,
highlighting
its
potential
as
upcoming
biomarker
therapeutic
target.
Methods:
A
search
studies
published
2019
2024
conducted
using
PubMed,
Cochrane
Library,
Web
Science,
focusing
research
related
chemerin,
PCOS-related
features,
comorbidities,
complications.
qualitative
structured
synthesis
key
findings
performed
according
specific
thematic
areas
selected,
including
discussing
clinical
experimental
humans
animal
models
PCOS.
Results:
Available
increased
levels
compared
controls,
independent
obesity
body
mass
index.
Chemerin
associated
insulin
resistance,
hyperandrogenism,
ovarian
dysfunction
individuals,
inhibiting
folliculogenesis
steroidogenesis.
Experimental
underscore
chemerin’s
regulatory
roles
through
receptors
within
hypothalamic–pituitary–ovarian
axis
peripheral
tissues.
High
systemic
may
also
be
risk
pregnancy
complications,
especially
gestational
diabetes
mellitus
preeclampsia.
Conclusions:
highlights
pathophysiology,
severity,
comorbidities
assessing
value
future
foreshadowing
Language: Английский
Relationship between smoking, excessive androgen and negative emotions in women with polycystic ovary syndrome (PCOS)
Yang Yang,
No information about this author
Hua Zhang,
No information about this author
Boyun Huang
No information about this author
et al.
Journal of Ovarian Research,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: Oct. 29, 2024
Lifestyle
intervention
is
the
first-line
treatment
for
PCOS.
Numerous
studies
have
investigated
effect
of
various
lifestyle
factors,
including
dietary
habit,
smoking,
and
alcohol
consumption
on
PCOS
women.
These
found
that
such
factors
may
be
associated
with
physiological
parameters
as
androgen,
emotional
states
like
anxiety
or
depression.
Smoking,
a
harmful
habit
widely
recognized
to
contribute
diseases,
has
also
been
related
Current
research
not
adequately
compared
effects
smoking
other
habits
PCOS,
there
little
mention
its
relationship
patients
To
further
elucidate
association
between
clinical
symptoms
in
we
conducted
cross-sectional
evaluation
using
data
from
Peking
University
Third
Hospital,
special
focus
analyzing
comparing
it
variety
factors.
This
study
included
601
women
184
healthy
controls
who
underwent
physical
examinations,
hormone
profiles
psychological
measures.
We
assessed
significant
correlation
degree
depression
among
three
states:
anxiety,
depression,
stress.
Smoking
was
significantly
testosterone
level
participants,
suggesting
smoke
exhibited
more
severe
depressive
higher
level.
In
addition,
control
group,
had
notably
(T)
luteinizing
(LH)
levels.
Smoke
were
statistically
common
than
Control.
Women
elevated
levels
findings
suggest
clinicians
should
monitor
assess
their
hyperandrogenic
status.
Language: Английский